Arch Oncology Investors, LLC — Form D

Arch Oncology Investors, LLC of Portland, OR, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2021-05-10. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-05-10
• Form: D
• Accession: 0001861423-21-000001
• Industry: Biotechnology
• Exemptions: 3C, 3C.1
• Total offering: $11.0M
• Amount sold: $11.0M
• Minimum investment: $25K
• Investors: 40
• Date of first sale: 2021-04-26
• Security types: fund interests
• Revenue range: $1,000,001 - $5,000,000
• SEC file number: 021-398844

Issuer

• Name: Arch Oncology Investors, LLC
• CIK: 0001861423
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 2540 NE Martin Luther King Jr Blvd, Portland, OR, 97212
• Phone: 503-808-7900

Officers, directors & promoters (2)

More

• CIK 1861423 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search